new Alzheimer's drug, Exelon (rivastigmine)

You'll be hearing a lot about the new Alzheimer's drug, Exelon (rivastigmine) from Novartis.

Exelon is a cholinesterase inhibitor...similar to Aricept.

These drugs offer modest benefits for patients with mild to moderate Alzheimer's. They may slightly improve cognitive abilities and delay the need for nursing home placement.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote